Hospira Announces A Nationwide Recall of Certain Lots of Injectable Carboplatin, Cytarabine, Paclitaxel and Methotrexate Due to Glass Vial Defect FOR IMMEDIATE RELEASE -July 13, 2012 – Hospira, Inc. (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, issued this press release today to further inform the general public about a previously […]
Report from the FDA: April 17, 2015 The U.S. Food and Drug Administration is alerting pet owners, veterinarians, health care providers and pharmacists that pets are at risk of illness and death when exposed to topical pain medications containing the nonsteroidal anti-inflammatory drug (NSAID) flurbiprofen. People using these medications, should use care when applying them […]
